Untitled Publication

Tsoh J, Apollonio DE, Hall S, Vijayaraghvan M, Ramo DE, Ling P, Lempert LL, Glantz SA. FDA’s Nicotine Steering Committee should develop policies, regulations, and procedures that promote cessation and increase the use of proven therapies. US FDA Public Comment, Docket FDA-2018-N-0128.

Untitled Publication

Apollonio DE, Glantz SA, Hall S, Lempert LL, St.Helen G, Tsoh J. The FDA should not adopt the nicotine “harm reduction” paradigm because doing so is likely to increase the amount of smoking-caused disease and death. US FDA Public Comment, Docket FDA-2017-N-6529.

Gathering the Fish and Casting a Net: San Francisco's Children's Oral Health Strategic Plan.

Susan Fisher-Owens, Carolyn L Brown, Lisa Chung, Margaret Fisher, Stuart Gansky, Amor Santiago, Kevin Grumbach

Illicit Drug Trends Globally.

Liesbeth Vandam, João Matias, Rebecca McKetin, Meredith Meacham, Paul Griffiths

Illicit Drug Trends Globally.

Liesbeth Vandam,João Matias,Rebecca McKetin,Meredith Meacham,Paul Griffiths

20.

Pages